SEC 13F Intelligence

Paragon Associates & Paragon Associates II Joint Venture / ABBV

Paragon Associates & Paragon Associates II Joint Venture’s Abbvie Inc Position

Does Paragon Associates & Paragon Associates II Joint Venture own Abbvie Inc (ABBV)? Not currently — the last reported position was 60.0K shares worth $6M in Q2 2020; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$6M
Q2 2020
Shares
60.0K
% of Portfolio
+6.47%
Quarters Held
4
position exited

Position History ABBV

Reported value by quarter
Q2 ’19: $727,000Q2 ’19Q3 ’19: $11MQ3 ’19Q4 ’19: $13MQ4 ’19Q2 ’20: $6MQ2 ’20filingsflow.com
QuarterSharesValue% of Portfolio
Q2 202060.0K$6M+6.47%
Q4 2019150.0K$13M+7.46%
Q3 2019150.0K$11M+8.77%
Q2 201910.0K$727,000+0.56%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Paragon Associates & Paragon Associates II Joint Venture’s full portfolio or all institutional holders of ABBV.